首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 贾伟
2024
CA
Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity
Cell Metab, 10.1016/j.cmet.2024.03.010
CA
LiveBoost: A GB-based prediction system for liver fibrosis in chronic hepatitis B patients in China - A multi-center retrospective study
Heliyon, 10.1016/j.heliyon.2024.e24161
2023
CA
Targeting gut microbial nitrogen recycling and cellular uptake of ammonium to improve bortezomib resistance in multiple myeloma
Cell Metab, 10.1016/j.cmet.2023.11.019
点击查看热心肠日报解读
CA
Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex-Dependent Manner
ADV SCI, 10.1002/advs.202306576
FA
CA
Unveiling Insights into Ovarian Cancer Metabolism through Space- and Time-Resolved Analysis
Cancers, 10.3390/cancers15194881
CA
Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome
Nat Commun, 10.1038/s41467-023-40552-y
点击查看热心肠日报解读
CA
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
Cell Metab, 10.1016/j.cmet.2023.07.011
点击查看热心肠日报解读
FA
Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis
Sci China Life Sci, 10.1007/s11427-023-2353-0
CA
Exploiting the bile acid-activated receptors-specific innate and adaptive immune system: drug and agent approaches
EUR J IMMUNOL, 10.1002/eji.202250299
CA
Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis
MOL THER, 10.1016/j.ymthe.2023.01.018
点击查看热心肠日报解读
CA
Extracellular vesicles derived from host and gut microbiota as promising nanocarriers for targeted therapy in osteoporosis and osteoarthritis
FPHAR, 10.3389/fphar.2022.1051134
2022
CA
Gut microbiota and colorectal cancer metastasis
Cancer Lett, 10.1016/j.canlet.2022.216039
点击查看热心肠日报解读
CA
Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills (T101) against cardiac structural and functional abnormalities
FPHAR, 10.3389/fphar.2022.1017433
Targeted metabolomics reveals aberrant profiles of serum bile acids in patients with schizophrenia
10.1038/s41537-022-00273-5
CA
Serum Amino Acid Profiles Predict the Development of Hepatocellular Carcinoma in Patients with Chronic HBV Infection
ACS Omega, 10.1021/acsomega.2c00885
CA
Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice
Nat Commun, 10.1038/s41467-022-29589-7
点击查看热心肠日报解读
CA
Bile Acid-Microbiome Interaction Promotes Gastric Carcinogenesis
ADV SCI, 10.1002/advs.202200263
点击查看热心肠日报解读
2021
CA
The microbial metabolome in metabolic-associated fatty liver disease
J GASTROEN HEPATOL, 10.1111/jgh.15746
CA
Altered bile acid glycine : taurine ratio in the progression of chronic liver disease
J GASTROEN HEPATOL, 10.1111/jgh.15709
CA
Altered bile acid glycine : taurine ratio in the progression of chronic liver disease
J GASTROEN HEPATOL, 10.1111/jgh.15709